Bloomios (BLMS) Stock Price, News & Analysis
Company Description
Bloomios (OTC Link: BLMS) is classified in the drug manufacturers - specialty & generic industry within the Healthcare sector and carries a market capitalization of $6.4K.
BLMS has gained 200.0% over the past year. Shares last traded at $0.0003.
This page collects what Stock Titan holds for BLMS, including price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Bloomios (BLMS) stock last traded at $0.0003. Over the past 12 months, the stock has gained 200.0%. At a market capitalization of $6.4K, BLMS is classified as a micro-cap stock with approximately 64.5M shares outstanding.
Latest News
Bloomios has 10 recent news articles. Of the recent coverage, 3 articles coincided with positive price movement and 3 with negative movement. Key topics include earnings, management, conferences. View all BLMS news →
SEC Filings
Financial Highlights
Upcoming Events
Short Interest History
Days to Cover History
BLMS Company Profile & Sector Positioning
Bloomios (BLMS) operates in the Drug Manufacturers - Specialty & Generic industry within the broader Healthcare sector and is listed on the OTC Link.
Investors comparing BLMS often look at related companies in the same sector, including Avivagen (VIVXF), Item 9 Labs (INLB), Halo Collective Inc (HCANF), Bzam Ltd (BZAMF), and Veritas Farms (VFRM). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate BLMS's relative position within its industry.